A review of dosimetric impact of implementation of model-based dose calculation algorithms (MBDCAs) for HDR brachytherapy
- 17 June 2021
- journal article
- review article
- Published by Springer Nature in Physical and Engineering Sciences in Medicine
- Vol. 44 (3) , 871-886
Abstract
To obtain dose distributions more physically representative to the patient anatomy in brachytherapy, calculation algorithms that can account for heterogeneity are required. The current standard AAPM Task Group No 43 (TG-43) dose calculation formalism has some clinically relevant dosimetric limitations. Lack of tissue heterogeneity and scattered dose corrections are the major weaknesses of the TG-43 formalism and could lead to systematic dose errors in target volumes and organs at risk. Over the last decade, model-based dose calculation algorithms (MBDCAs) have been clinically offered as complementary algorithms beyond the TG43 formalism for high dose rate (HDR) brachytherapy treatment planning. These algorithms provide enhanced dose calculation accuracy by using the information in the patient’s computed tomography images, which allows modeling the patient’s geometry, material compositions, and the treatment applicator. Several researchers have investigated the implementation of MBDCAs in HDR brachytherapy for dose optimization, but moving toward using them as primary algorithms for dose calculations is still lagging. Therefore, an overview of up-to-date research is needed to familiarize clinicians with the current status of the MBDCAs for different cancers in HDR brachytherapy. In this paper, we review the MBDCAs for HDR brachytherapy from a dosimetric perspective. Treatment sites covered include breast, gynecological, lung, head and neck, esophagus, liver, prostate, and skin cancers. Moreover, we discuss the current status of implementation of MBDCAs and the challenges.Keywords
This publication has 64 references indexed in Scilit:
- Dosimetric accuracy of a deterministic radiation transport based 192Ir brachytherapy treatment planning system. Part III. Comparison to Monte Carlo simulation in voxelized anatomical computational modelsMedical Physics, 2012
- Dosimetry comparison between TG-43 and Monte Carlo calculations using the Freiburg flap for skin high-dose-rate brachytherapyBrachytherapy, 2012
- Report of the Task Group 186 on model‐based dose calculation methods in brachytherapy beyond the TG‐43 formalism: Current status and recommendations for clinical implementationMedical Physics, 2012
- Impact of Heterogeneity-Based Dose Calculation Using a Deterministic Grid-Based Boltzmann Equation Solver for Intracavitary BrachytherapyInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2012
- Dose calculation for photon‐emitting brachytherapy sources with average energy higher than 50 keV: Report of the AAPM and ESTROMedical Physics, 2012
- Methodology for commissioning a brachytherapy treatment planning system in the era of 3D planningAustralasian Physics & Engineering Sciences in Medicine, 2010
- Effect of inhomogeneities and source position on dose distribution of nucletron high dose rate Ir-192 brachytherapy source by Monte Carlo simulationJournal of Cancer Research and Therapeutics, 2010
- The evolution of brachytherapy treatment planningMedical Physics, 2009
- EGSnrc Monte Carlo calculated dosimetry parameters for and brachytherapy sourcesMedical Physics, 2008
- Supplement to the 2004 update of the AAPM Task Group No. 43 ReportMedical Physics, 2007